0,838  0,005  Chemoprotective
0,822  0,013  Antiinflammatory
0,806  0,004  Skin irritative effect
0,796  0,008  CYP2C9 substrate
0,774  0,008  Carcinogenic
0,763  0,003  UGT1A4 substrate
0,756  0,002  Vanilloid agonist
0,750  0,001  Alcohol dehydrogenase substrate
0,765  0,021  Apoptosis agonist
0,755  0,012  Teratogen
0,744  0,006  Sensitization
0,745  0,012  Embryotoxic
0,742  0,010  Antileukemic
0,727  0,017  Antineoplastic (breast cancer)
0,709  0,007  CYP2C19 substrate
0,673  0,004  Carcinogenic, group 3
0,661  0,005  Psychostimulant
0,646  0,009  Antineoplastic (melanoma)
0,641  0,006  UGT1A1 substrate
0,638  0,008  Antineoplastic (pancreatic cancer)
0,638  0,009  Proliferative diseases treatment
0,641  0,012  Antineoplastic (ovarian cancer)
0,638  0,025  Antineoplastic (lung cancer)
0,605  0,010  NOS2 expression inhibitor
0,596  0,006  Antineoplastic (endocrine cancer)
0,600  0,013  Chemopreventive
0,600  0,023  Antineoplastic (colorectal cancer)
0,589  0,019  Respiratory analeptic
0,574  0,011  Nitric oxide antagonist
0,575  0,024  Antineoplastic (colon cancer)
0,560  0,012  Antineoplastic (multiple myeloma)
0,547  0,003  Expectorant
0,570  0,035  Transcription factor NF kappa B inhibitor
0,553  0,020  Immunosuppressant
0,544  0,016  Antiepileptic
0,543  0,018  Mutagenic
0,539  0,026  Prostate cancer treatment
0,521  0,009  Sedative
0,508  0,004  UGT2B7 substrate
0,496  0,004  5 Hydroxytryptamine uptake stimulant
0,492  0,003  UGT2B9 substrate
0,492  0,010  Antihelmintic
0,497  0,016  Antiparasitic
0,506  0,026  Bone diseases treatment
0,487  0,012  UDP-glucuronosyltransferase substrate
0,481  0,009  Antiviral (HIV)
0,487  0,018  Antiprotozoal (Leishmania)
0,471  0,005  Antiviral (Influenza A)
0,489  0,025  Spasmolytic
0,475  0,017  Antiglaucomic
0,476  0,023  Antineoplastic (glioma)
0,462  0,009  Hair growth stimulant
0,474  0,025  Analeptic
0,506  0,058  Caspase 9 stimulant
0,454  0,015  Antineoplastic (liver cancer)
0,446  0,006  Antiviral (Influenza)
0,441  0,002  Actinic keratosis treatment
0,446  0,016  Angiogenesis stimulant
0,454  0,028  Antineoplastic (cervical cancer)
0,450  0,029  AR expression inhibitor
0,426  0,009  Antiacne
0,428  0,023  Antineoplastic (glioblastoma multiforme)
0,454  0,051  GST A substrate
0,410  0,008  Protein kinase stimulant
0,415  0,014  Abortion inducer
0,436  0,035  Antifungal
0,408  0,008  Pneumotoxic
0,456  0,059  TNF expression inhibitor
0,411  0,019  Antineoplastic (osteosarcoma)
0,416  0,027  UGT2B4 substrate
0,406  0,036  Antiosteoporotic
0,411  0,041  Caspase 3 stimulant
0,390  0,020  Antineoplastic (lymphocytic leukemia)
0,370  0,003  Transcription factor NF kappa B stimulant
0,380  0,014  Platelet adhesion inhibitor
0,430  0,064  Antibacterial
0,400  0,041  Antipsoriatic
0,361  0,004  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,376  0,025  DNA synthesis inhibitor
0,364  0,013  Antialcoholic
0,385  0,038  Antioxidant
0,349  0,003  Aldehyde dehydrogenase substrate
0,395  0,050  Cholesterol antagonist
0,352  0,018  Antihypotensive
0,356  0,023  Eye irritation, high
0,358  0,034  Antineoplastic (renal cancer)
0,358  0,036  Tumour necrosis factor alpha release inhibitor
0,343  0,024  Muscle relaxant
0,372  0,058  Immunostimulant
0,316  0,004  Mucolytic
0,351  0,045  Interleukin 2 agonist
0,346  0,044  Antineurogenic pain
0,303  0,005  Choleretic
0,335  0,037  Vasodilator
0,312  0,015  Antihelmintic (Nematodes)
0,338  0,044  Cytostatic
0,297  0,004  Vanilloid 1 agonist
0,348  0,057  Apoptosis antagonist
0,331  0,046  Cytotoxic
0,307  0,023  Antiviral (Herpes)
0,340  0,056  Antineoplastic (brain cancer)
0,334  0,055  Antihypercholesterolemic
0,318  0,040  Interleukin agonist
0,302  0,025  VCAM1 expression inhibitor
0,298  0,022  Antipruritic, non-allergic
0,341  0,066  FMO1 substrate
0,356  0,087  Antipruritic, allergic
0,285  0,018  Alpha-N-acetylglucosaminidase inhibitor
0,277  0,013  Antifungal enhancer
0,268  0,005  GABA C receptor antagonist
0,276  0,025  Antineoplastic (carcinoma)
0,269  0,026  Melanin inhibitor
0,245  0,004  Ca(v)3.1 blocker
0,308  0,067  5 Hydroxytryptamine release stimulant
0,268  0,028  Antianorexic
0,262  0,026  Interferon gamma antagonist
0,241  0,006  TRPA1 agonist
0,266  0,034  Antimutagenic
0,251  0,022  Succinate dehydrogenase inhibitor
0,244  0,017  Alkylator
0,264  0,040  Hepatoprotectant
0,280  0,057  Free radical scavenger
0,237  0,017  UGT2B10 substrate
0,261  0,043  RNA-directed DNA polymerase inhibitor
0,294  0,078  NOS3 expression inhibitor
0,276  0,062  Antidiabetic symptomatic
0,221  0,008  Antiviral (Influenza B)
0,279  0,065  Antineoplastic (non-small cell lung cancer)
0,339  0,126  Calcium channel L-type activator
0,276  0,065  Antipyretic
0,273  0,062  Cardiovascular analeptic
0,249  0,038  CYP2B6 inhibitor
0,314  0,106  Antineoplastic (myeloid leukemia)
0,221  0,015  Microtubule formation inhibitor
0,208  0,005  5-Alpha-reductase inhibitor
0,214  0,013  Menstruation disorders treatment
0,290  0,096  ICAM1 expression inhibitor
0,220  0,034  Acetylcholine M1 receptor antagonist
0,196  0,010  Posttraumatic stress disorder treatment
0,224  0,039  Acaricide
0,212  0,029  Carcinogenic, group 1
0,253  0,075  Hypoglycemic
0,310  0,134  Antiparkinsonian
0,284  0,109  CYP3A4 substrate
0,282  0,111  Calcium channel activator
0,210  0,039  UGT2B15 substrate
0,207  0,042  Prostate disorders treatment
0,186  0,021  Adenylate cyclase stimulant
0,256  0,091  GST M1-1 substrate
0,196  0,031  Cell wall synthesis inhibitor
0,227  0,067  Antihypertriglyceridemic
0,179  0,025  Antineoplastic antibiotic
0,192  0,041  Arachidonic acid antagonist
0,235  0,085  Vascular (periferal) disease treatment
0,171  0,027  GABA C receptor agonist
0,145  0,004  Vanilloid 4 agonist
0,181  0,040  SULT1A3 substrate
0,158  0,019  Porphobilinogen synthase inhibitor
0,143  0,005  TRPM8 blocker
0,154  0,016  Anabolic
0,177  0,043  Antiseptic
0,180  0,048  CNS active muscle relaxant
0,140  0,008  Na+ K+ transporting ATPase inhibitor
0,242  0,111  CYP2D6 substrate
0,146  0,017  UGT2B11 substrate
0,200  0,076  Neurotrophic factor enhancer
0,218  0,094  Myocardial infarction treatment
0,249  0,127  Antithrombotic
0,139  0,023  Triose-phosphate isomerase inhibitor
0,121  0,005  Kainate receptor antagonist
0,148  0,033  Antiviral (CMV)
0,150  0,037  Antiviral (Poxvirus)
0,177  0,064  Phospholipase C inhibitor
0,135  0,025  GST T1-1 substrate
0,189  0,080  Non-steroidal antiinflammatory agent
0,130  0,021  Antiviral (Rhinovirus)
0,123  0,015  GABA aminotransferase inhibitor
0,124  0,016  Glycine receptor antagonist
0,126  0,022  Ornithine decarboxylase inhibitor
0,122  0,019  CDC25A inhibitor
0,214  0,112  Tyrosine 3 hydroxylase inhibitor
0,194  0,092  Antiparkinsonian, rigidity relieving
0,147  0,046  Protein-tyrosine phosphatase 1B inhibitor
0,103  0,003  Kainate receptor agonist
0,210  0,111  Antineoplastic (sarcoma)
0,147  0,049  Ca2+-transporting ATPase inhibitor
0,124  0,026  Antibiotic
0,217  0,120  Radiosensitizer
0,101  0,005  Retinoid X receptor agonist
0,118  0,026  Phosphofructokinase-1 inhibitor
0,132  0,040  AMP-activated protein kinase stimulant
0,126  0,034  Prolactin inhibitor
0,131  0,039  UGT2B1 substrate
0,147  0,056  Skin whitener
0,104  0,014  Cannabinoid CB2 receptor antagonist
0,121  0,031  Antispirochetal
0,109  0,019  HIV-1 integrase (Strand Transfer) inhibitor
0,161  0,072  Uterine stimulant
0,226  0,137  CTGF expression inhibitor
0,110  0,022  Interferon agonist
0,143  0,056  Cholinergic antagonist
0,189  0,103  Antineoplastic (lymphoma)
0,141  0,055  Acetylcholine antagonist
0,104  0,021  Narcotic antagonist
0,130  0,049  Glutathione S-transferase substrate
0,152  0,072  CF transmembrane conductance regulator agonist
0,094  0,015  Interferon inducer
0,172  0,093  Anesthetic general
0,086  0,008  Anesthetic inhalation
0,177  0,099  Insulin sensitizer
0,269  0,192  Cyclophilin D inhibitor
0,269  0,192  Antidiabetic
0,226  0,148  Vasodilator, peripheral
0,081  0,004  Glutamate (mGluR1) agonist
0,148  0,071  Genotoxic
0,121  0,044  GST P1-1 substrate
0,152  0,077  Protein-tyrosine phosphatase inhibitor
0,096  0,022  Dysmenorrhea treatment
0,112  0,039  Carcinogenic, group 2A
0,118  0,045  Adenylate kinase inhibitor
0,155  0,082  Antiviral (Hepatitis C)
0,100  0,027  Lipase inhibitor
0,074  0,002  Vanilloid 2 agonist
0,105  0,033  ATPase (Vacuolar H+) inhibitor
0,116  0,046  UDP-glucose 4-epimerase inhibitor
0,129  0,059  Acetylcholine muscarinic antagonist
0,123  0,053  Photosensitizer
0,107  0,038  Antidote, mercury
0,103  0,035  CYP2A6 inhibitor
0,113  0,046  Antihypermotility
0,070  0,004  Tubulin agonist
0,193  0,128  Lipoprotein disorders treatment
0,115  0,052  Antiprotozoal (Toxoplasma)
0,213  0,149  Immunomodulator
0,096  0,033  Keratolytic
0,117  0,055  Ferrochelatase inhibitor
0,118  0,056  Excitatory amino acid transporter EAAC1 inhibitor
0,134  0,074  Farnesoid X receptor antagonist
0,135  0,076  Antineoplastic (squamous cell carcinoma)
0,083  0,025  Gaucher disease treatment
0,078  0,021  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,073  0,017  Aconitate hydratase inhibitor
0,097  0,041  Acetylcholine nicotinic antagonist
0,101  0,047  Antineoplastic alkaloid
0,204  0,149  CYP1A2 substrate
0,113  0,059  Carcinogenic, group 2B
0,152  0,098  ATPase inhibitor
0,079  0,025  Glutamate (mGluR6) antagonist
0,085  0,032  Glycine receptor agonist
0,062  0,009  GABA uptake inhibitor
0,174  0,121  UGT1A6 substrate
0,125  0,073  Toll-Like receptor 2 antagonist
0,118  0,067  Cholesterol synthesis inhibitor
0,071  0,020  Postcoital contraceptive
0,156  0,107  Antiviral (Hepatitis)
0,102  0,054  DNA directed RNA polymerase inhibitor
0,099  0,050  Paget's disease treatment
0,058  0,010  Retinoic acid alpha receptor agonist
0,074  0,026  Hypercalcemia treatment
0,074  0,027  Antimycoplasmal
0,061  0,016  Factor III inhibitor
0,060  0,015  Microtubule stabilization
0,071  0,026  Estrogen agonist
0,049  0,005  Adenosine uptake inhibitor
0,223  0,180  GABA C receptor rho-3 antagonist
0,102  0,060  GABA C receptor rho-1 antagonist
0,047  0,007  5-Alpha-reductase 1 inhibitor
0,135  0,096  UGT1A3 substrate
0,071  0,032  Biliverdin reductase inhibitor
0,122  0,083  Contraceptive
0,138  0,099  Movement disorders treatment
0,049  0,012  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,041  0,004  Alpha 2b adrenoreceptor agonist
0,064  0,027  Sphingosine kinase 2 inhibitor
0,188  0,151  Transcription factor STAT3 inhibitor
0,091  0,055  NADH dehydrogenase inhibitor
0,090  0,054  Interleukin 5 antagonist
0,045  0,013  Melatonin 2 agonist
0,063  0,031  Acyl-CoA dehydrogenase inhibitor
0,065  0,034  Prolactin release inhibitor
0,038  0,007  Retinoic acid receptor agonist
0,114  0,083  M17 leucyl aminopeptidase inhibitor
0,054  0,024  Glucose-6-phosphate isomerase inhibitor
0,156  0,126  Antiulcerative
0,063  0,034  Sphingosine kinase inhibitor
0,065  0,036  Alpha 2 adrenoreceptor agonist
0,047  0,018  Kainate receptor 2 antagonist
0,115  0,086  Antihyperlipoproteinemic
0,110  0,082  Antiviral (Hepatitis B)
0,076  0,048  Glutamate dehydrogenase inhibitor
0,044  0,017  Retinoid X alpha receptor agonist
0,091  0,064  HIV-1 integrase (Overall Integration) inhibitor
0,083  0,056  Antiviral (Dengue virus)
0,054  0,027  Antiviral (Herpesvirus 3, Human)
0,083  0,057  Antiprotozoal activity enhancer
0,112  0,086  Amylase inhibitor
0,113  0,088  Anesthetic
0,058  0,033  Dihydroorotate oxidase inhibitor
0,033  0,009  Retinoid X gamma receptor antagonist
0,056  0,033  Alpha-mannosidase inhibitor
0,062  0,041  Cannabinoid CB1 receptor agonist
0,089  0,068  ABCA1 expression enhancer
0,127  0,106  Antifungal (Cryptococcus)
0,025  0,004  O6-alkylguanine-DNA alkyltransferase inhibitor
0,100  0,079  SULT1A1 substrate
0,103  0,083  Antiviral (SARS coronavirus)
0,103  0,083  Antiviral (Coronavirus)
0,195  0,175  FMO3 substrate
0,027  0,008  Retinoic acid gamma receptor agonist
0,027  0,008  Vitamin D receptor antagonist
0,082  0,063  Androgen antagonist
0,068  0,050  Anticholelithogenic
0,025  0,007  Retinoid X beta receptor antagonist
0,102  0,084  Proteasome inhibitor
0,063  0,045  HIV-1 integrase (3'-Processing) inhibitor
0,180  0,162  UGT1A9 substrate
0,040  0,023  Retinoid X receptor antagonist
0,025  0,008  Retinoic acid beta receptor agonist
0,095  0,079  Toll-Like receptor 4 antagonist
0,028  0,012  Retinoid X gamma receptor agonist
0,036  0,020  Retinoid X alpha receptor antagonist
0,091  0,075  Sulfotransferase substrate
0,079  0,064  Thioredoxin reductase inhibitor
0,095  0,080  Monophenol monooxygenase inhibitor
0,029  0,014  Nicotinic acid receptor 2 antagonist
0,169  0,155  Nitric-oxide synthase stimulant
0,099  0,085  Electron transport complex I inhibitor
0,048  0,035  Dopamine beta hydroxylase inhibitor
0,075  0,062  MAP kinase kinase 7 inhibitor
0,045  0,032  Parathyroid hormone antagonist
0,024  0,012  Retinoid X beta receptor agonist
0,048  0,036  Cytokine production stimulant
0,104  0,092  Shock treatment
0,039  0,027  Membrane dipeptidase inhibitor
0,119  0,108  Antidote
0,119  0,110  Skeletal muscle relaxant
0,081  0,072  Granulocyte macrophage colony stimulating factor agonist
0,042  0,033  Glutamate (mGluR4) antagonist
0,136  0,127  Antineoplastic (gastric cancer)
0,094  0,086  Chelator
0,088  0,079  Bile acid receptor antagonist
0,145  0,137  Antirickettsial
0,105  0,098  Contraceptive female
0,057  0,049  Cannabinoid CB1 receptor antagonist
0,037  0,030  Vanilloid 3 antagonist
0,144  0,137  Anticonvulsant
0,059  0,052  Antiviral (Parainfluenza)
0,119  0,113  Insulin secretagoues
0,047  0,042  Prolyl endopeptidase inhibitor
0,047  0,043  Protein 50S ribosomal subunit inhibitor
0,036  0,031  Glutamate (mGluR8) agonist
0,021  0,017  Geranylgeranyltransferase inhibitor
0,016  0,013  Vitamin D receptor agonist
0,174  0,171  Antihypoxic
0,043  0,041  Cholesterol esterase inhibitor
0,060  0,058  Calcium channel P-type blocker
0,021  0,019  Prostaglandin F2 alpha agonist
0,016  0,015  Telomerase stimulant
0,019  0,019  Neuraminidase (Influenza B) inhibitor
0,040  0,039  Mannosidase inhibitor
0,025  0,025  Estrogen receptor beta agonist

